Merck KGaA (FRA:MRK) has been assigned a €103.00 ($115.73) price target by stock analysts at Morgan Stanley in a research report issued to clients and investors on Monday. The brokerage presently has a “neutral” rating on the healthcare company’s stock.

MRK has been the topic of several other research reports. BNP Paribas set a €114.00 ($128.09) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Tuesday, February 28th. Warburg Research set a €110.00 ($123.60) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Wednesday, February 22nd. Deutsche Bank AG set a €118.00 ($132.58) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Monday, February 20th. Citigroup Inc set a €116.00 ($130.34) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Wednesday, March 1st. Finally, Goldman Sachs Group Inc set a €105.00 ($117.98) target price on Merck KGaA and gave the stock a “neutral” rating in a research note on Tuesday, January 24th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of €109.29 ($122.79).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) traded down 1.119% during trading on Monday, reaching €106.691. The company’s stock had a trading volume of 2,627 shares. Merck KGaA has a 1-year low of €80.99 and a 1-year high of €115.00. The stock has a 50 day moving average price of €107.75 and a 200 day moving average price of €101.76. The stock has a market capitalization of €46.32 billion and a PE ratio of 29.744.

ILLEGAL ACTIVITY NOTICE: “Merck KGaA (MRK) Given a €103.00 Price Target by Morgan Stanley Analysts” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.americanbankingnews.com/2017/05/22/merck-kgaa-mrk-given-a-103-00-price-target-by-morgan-stanley-analysts-2.html.

About Merck KGaA

.

12 Month Chart for FRA:MRK

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.